Skip to main content
. 2022 Aug 22;29(8):5963–5987. doi: 10.3390/curroncol29080471

Figure 2.

Figure 2

CTSK promotes the invasion and metastasis of prostate cancer, which is related to the receptor activator of NF-κB (RANK) and proinflammatory factors such as interleukin 6 (IL-6).